Results 41 to 50 of about 71,425 (202)

Mid-Ventricular Hypertrophic Obstructive Cardiomyopathy [PDF]

, 2014
Mid-ventricular hypertrophic obstructive cardiomyopathy is a rare variant form (1%) of hypertrophic obstructive cardiomyopathy. In this case, we report a patient referred for elective cardiac catheterization due to angina and dyspnea on moderate exertion,
Pivatto Junior, Fernando, Pivatto, Fernando, Krepsky, Ana Maria Rocha, Zago, Alexandre do Canto, Krepsky, Ana Maria, Mossmann, Márcio   +5 more
core   +1 more source

Hypertrophic Cardiomyopathy: Challenging the Status Quo?

, 2020
Hypertrophic cardiomyopathy (HCM) is the most common cardiovascular genetic disorder. While our mechanistic understanding has been informed by elegant gene discovery studies that led to the term “disease of the sarcomere”, more recent investigations have
McCormack, L, Atherton, JJ, Younger, J, Lo, A, McGaughran, J, Prasad, S   +5 more
core   +1 more source

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy [PDF]

, 2005
Hypertrophic cardiomyopathy (HCM) is an important cardiovascular disease with sudden cardiac death as the most devastating presentation. Implantable cardioverter defibrillators (ICD) are the optimal therapy for prevention of sudden death from ventricular
Maron, Barry J., Barry J. Maron, Johnson Francis, Francis, Johnson, Ghosh, Joydeep, Joydeep Ghosh   +5 more
core  

Disopyramide for Hypertrophic Cardiomyopathy [PDF]

Cureus, 2019
Hypertrophic cardiomyopathy (HCM) is a cardiac disease characterized by hypertrophy of a nondilated left ventricle without any other cardiac or systemic disease that could account for observed hypertrophy. We present a female patient with the diagnosis of obstructive HCM, which is rare because sudden death is frequently the first clinical presentation. 
Sanchez-Nadales, Alejandro, Anampa-Guzmán, Andrea, Khan, Amir   +2 more
openaire   +2 more sources

Echocardiography-guided percutaneous intramyocardial alginate hydrogel implants for heart failure: canine models with 6-month outcomes

Frontiers in Cardiovascular Medicine
BackgroundEchocardiography-guided percutaneous intramyocardial alginate-hydrogel implantation (PIMAHI) is a novel treatment approach for heart failure (HF).
Hui Ma, Wenqing Gong, D. Scott Lim, Jing Li, Shengjun Ta, Rui Hu, Xiaojuan Li, Minjuan Zheng, Liwen Liu   +8 more
doaj   +1 more source

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).

, 2014
Aims: Hypertrophic cardiomyopathy(HCM)is a leading cause of sudden cardiac death (SCD) in young adults. Current risk algorithms provide only a crude estimate of risk and fail to account for the different effect size of individual risk factors. The aim of
Hypertrophic Cardiomyopathy Outcomes Investigators, RAPEZZI, CLAUDIO, Pavlou M, Biagini E, Anastasakis A, McKenna WJ, Rapezzi C, Elliott PM, Omar RZ, O'Mahony C, Jichi F, BIAGINI, ELENA, Gimeno JR, Monserrat L, Limongelli G   +14 more
core   +1 more source

Predictive value of estimated plasma volume for postoperative hypotension in percutaneous intramyocardial septal radiofrequency ablation treating for hypertrophic obstructive cardiomyopathy

BMC Cardiovascular Disorders
Background Estimated plasma volume status (ePVS) estimated by the Duarte formula is associated with clinical outcomes in patients with heart failure.
Bo Shan, Jing Li, Zhangwei Shi, Chao Han, Juan Zhang, Jia Zhao, Rui Hu, Liwen Liu, Shengjun Ta   +8 more
doaj   +1 more source

Free left ventricular wall rupter in a newborn. [PDF]

, 2015
Free left ventricular wall rupture is very rare but mostly fatal complication of acute myocardial infarction in the elderly. Without the presence of congenital heart disease, preceding cardiac surgery or an isolated ventricular diverticulum ...
Wagner, Bendicht Peter, Hutter, Damian, Wagner, B., Kreiter, Bianca, Hutter, Damian Marco, Kadner, A, Riedel, T., Pfammatter, Jean-Pierre, Riedel, Thomas, Kadner, Alexander   +9 more
core  

Relaxation in hypertrophic cardiomyopathy and hypertensive heart disease: relations between hypertrophy and diastolic function

, 2000
AIM To determine the relation between the extent and distribution of left ventricular hypertrophy and the degree of disturbance of regional relaxation and global left ventricular filling.
Seiler, C., Allemann, Y., De Marchi, S. F., S F De Marchi   +3 more
core   +1 more source

Role of Septal Myectomy in Pediatric Hypertrophic Cardiomyopathy [PDF]

Hypertrophic cardiomyopathy is a prevalent cause of sudden cardiac death among young people. This distinctive genetic condition can manifest at any age from infancy to adulthood.
Sameh M. Said
core   +1 more source